CBOE vs RXRX · P/E 24, rev $2.72B vs rev $14.1M
Cboe Global Markets Inc (CBOE) versus Recursion Pharmaceuticals Inc (RXRX) — a side-by-side from cached financials, not a winner call.
Cboe Global Markets Inc (CBOE) is a financial data & stock exchanges company listed on US.
Recursion Pharmaceuticals Inc (RXRX) is a biotechnology company listed on NASDAQ.
Latest reported CBOE revenue for 2026-06-30 was $2.72B. Net income was $738.8M. CBOE currently screens at market cap $29.50B and trailing P/E 24.1.
Latest reported RXRX revenue for 2026-06-30 was $14.1M. Net income was -$248.5M. RXRX currently screens at market cap $1.75B.
CBOE currently screens at market cap $29.50B and trailing P/E 24.1. RXRX currently screens at market cap $1.75B.
Not investment advice. Open the CBOE and RXRX stock pages for the full models.
Not investment advice.